{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:53:38Z","timestamp":1792810418539,"version":"4.5.0"},"reference-count":257,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["125440785 \\u2013 SFB 877"],"award-info":[{"award-number":["125440785 \\u2013 SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["125440785"],"award-info":[{"award-number":["125440785"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 877"],"award-info":[{"award-number":["SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bbamcr.2022.119243","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T03:41:51Z","timestamp":1645587711000},"page":"119243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches"],"prefix":"10.1016","volume":"1869","author":[{"given":"Alice","family":"Drobny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susy","family":"Prieto Huarcaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josina","family":"Bunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Schlothauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Zunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2022.119243_bb0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1042\/bj0600604","article-title":"Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue","volume":"60","author":"De Duve","year":"1955","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1582-4934.2009.00973.x","article-title":"Role for LAMP-2 in endosomal cholesterol transport","volume":"15","author":"Schneede","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.200708010","article-title":"Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis","volume":"180","author":"Idone","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(01)00421-4","article-title":"Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes","volume":"106","author":"Reddy","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1083\/jcb.201003053","article-title":"Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair","volume":"189","author":"Tam","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0030","first-page":"22","article-title":"Lysosomes and lysosomal cathepsins in cell death","volume":"2012","author":"Repnik","year":"1824","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0952-7915(00)00177-1","article-title":"Antigen processing in the endocytic compartment","volume":"13","author":"Watts","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0050","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mcn.2015.01.003","article-title":"Chaperone mediated autophagy to the rescue: a new-fangled target for the treatment of neurodegenerative diseases","volume":"66","author":"Xilouri","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrm2755","article-title":"Pathways and mechanisms of endocytic recycling","volume":"10","author":"Grant","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-physiol-012110-142317","article-title":"Lysosomal acidification mechanisms","volume":"74","author":"Mindell","year":"2012","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","article-title":"Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy","volume":"27","author":"Eskelinen","year":"2006","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0080","series-title":"Lysosomal Proteases","first-page":"50","author":"Brix","year":"2005"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0085","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/pmic.201000196","article-title":"The proteome of lysosomes","volume":"10","author":"Schroder","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","article-title":"Cathepsins: proteases that are vital for survival but can also be fatal","volume":"105","author":"Patel","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1679\/aohc.64.233","article-title":"Autophagic cell death and its execution by lysosomal cathepsins","volume":"64","author":"Uchiyama","year":"2001","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.matbio.2018.01.024","article-title":"Cysteine cathepsins in extracellular matrix remodeling: extracellular matrix degradation and beyond","volume":"75\u201376","author":"Vizovisek","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0105","first-page":"2560","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"2014","author":"Fonovic","year":"1840","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030264","article-title":"Cysteine cathepsins and their extracellular roles: shaping the microenvironment","volume":"8","author":"Vidak","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bcp.2008.07.041","article-title":"Cathepsins: key modulators of cell death and inflammatory responses","volume":"76","author":"Conus","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0120","doi-asserted-by":"crossref","first-page":"19140","DOI":"10.1074\/jbc.M802513200","article-title":"Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues","volume":"283","author":"Droga-Mazovec","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0125","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s13277-015-4516-6","article-title":"The role of lysosome in cell death regulation","volume":"37","author":"Yu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/bj2640467","article-title":"Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins","volume":"264","author":"Kirschke","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071679","article-title":"The ins and outs of cathepsins: physiological function and role in disease management","volume":"9","author":"Yadati","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/med.21394","article-title":"The role of cathepsin D in the pathogenesis of human neurodegenerative disorders","volume":"36","author":"Vidoni","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140465","article-title":"Cathepsin regulation on microglial function","volume":"1868","author":"Nakanishi","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1673-5374.286948","article-title":"Cathepsins in neuronal plasticity","volume":"16","author":"Tran","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2008.08.099","article-title":"Cathepsin D: a cellular roadmap","volume":"376","author":"Zaidi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0160","series-title":"Proteases: Structure and Function","first-page":"127","article-title":"Cathepsins: getting in shape for lysosomal proteolysis","author":"Erickson","year":"2013"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010047","article-title":"Subcellular trafficking of mammalian lysosomal proteins: an extended view","volume":"18","author":"Staudt","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2008.06.021","article-title":"Sortilin mediates the lysosomal targeting of cathepsins D and H","volume":"373","author":"Canuel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0180","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/onc.2011.501","article-title":"Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis","volume":"31","author":"Derocq","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/tra.12284","article-title":"Lrp1\/LDL receptor play critical roles in mannose 6-phosphate-independent lysosomal enzyme targeting","volume":"16","author":"Markmann","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0190","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0700330104","article-title":"Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells","volume":"104","author":"Nielsen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1242\/jcs.179374","article-title":"Cathepsin D and its newly identified transport receptor SEZ6L2 can modulate neurite outgrowth","volume":"129","author":"Boonen","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0003-9861(88)90104-X","article-title":"Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro","volume":"261","author":"Nishimura","year":"1988","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4","article-title":"Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D","volume":"67","author":"van der Stappen","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0210","doi-asserted-by":"crossref","first-page":"33194","DOI":"10.1074\/jbc.M302742200","article-title":"Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice","volume":"278","author":"Shirahama-Noda","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0215","series-title":"Cathepsin B: Basis Sequence: Mouse","author":"Cavallo-Medved","year":"2011"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0225","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jb\/mvj037","article-title":"Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B","volume":"139","author":"Laurent-Matha","year":"2006","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.02.008","article-title":"Cathepsin D\u2013many functions of one aspartic protease","volume":"68","author":"Benes","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/375345","article-title":"Posttranslational processing and modification of cathepsins and cystatins","volume":"2010","author":"Katunuma","year":"2010","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0245","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0250","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","article-title":"Autophagy and aging","volume":"146","author":"Rubinsztein","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1568-1637(03)00027-8","article-title":"Neuronal and microglial cathepsins in aging and age-related diseases","volume":"2","author":"Nakanishi","year":"2003","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0260","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.06.002","article-title":"ADAM30 downregulates APP-linked defects through cathepsin D activation in Alzheimer's disease","volume":"9","author":"Letronne","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(96)01330-3","article-title":"Cathepsin D displays in vitro beta-secretase-like specificity","volume":"750","author":"Chevallier","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0270","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1046\/j.1471-4159.1997.69052026.x","article-title":"Degradation of tau by lysosomal enzyme cathepsin D: implication for alzheimer neurofibrillary degeneration","volume":"69","author":"Kenessey","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001026","article-title":"Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo","volume":"6","author":"Khurana","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0280","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/humu.20326","article-title":"The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease","volume":"27","author":"Riemenschneider","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0285","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JAD-132192","article-title":"Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-beta in Alzheimer's disease","volume":"42","author":"Tian","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0290","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jnnp.2005.063917","article-title":"Genetic associations between cathepsin D exon 2 C\u2013>T polymorphism and Alzheimer's disease, and pathological correlations with genotype","volume":"77","author":"Davidson","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0295","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1016\/S0021-9258(17)32325-6","article-title":"Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D","volume":"269","author":"Ladror","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-1-17","article-title":"Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity","volume":"1","author":"Qiao","year":"2008","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0305","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0310","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0320","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2005.11.012","article-title":"Lysosomal proteases are involved in generation of N-terminal huntingtin fragments","volume":"22","author":"Kim","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0325","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1093\/hmg\/ddg346","article-title":"Autophagy regulates the processing of amino terminal huntingtin fragments","volume":"12","author":"Qin","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-6-37","article-title":"Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons","volume":"6","author":"Liang","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0335","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1523\/JNEUROSCI.20-18-06898.2000","article-title":"Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons","volume":"20","author":"Koike","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0340","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","article-title":"Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis","volume":"16","author":"Marques","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0345","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mad.2013.08.001","article-title":"Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus","volume":"134","author":"Piyanova","year":"2013","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0350","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1523\/JNEUROSCI.21-19-07526.2001","article-title":"Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice","volume":"21","author":"Nakanishi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1997.9958","article-title":"Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside","volume":"341","author":"Hiraiwa","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0360","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.molmed.2020.07.004","article-title":"Pro-cathepsin D, prosaposin, and progranulin: lysosomal networks in parkinsonism","volume":"26","author":"Tayebi","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0365","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/BJ20040175","article-title":"Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation","volume":"383","author":"Gopalakrishnan","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0370","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","article-title":"Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis","volume":"129","author":"Siintola","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0375","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BJ20051677","article-title":"Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity","volume":"395","author":"Lewis","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0380","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/nen.0b013e318093ecc7","article-title":"Involvement of the endosomal-lysosomal system correlates with regional pathology in creutzfeldt-Jakob disease","volume":"66","author":"Kovacs","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0385","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/bc.2011.054","article-title":"Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer's disease","volume":"392","author":"Schechter","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167428","article-title":"Loss of cathepsin B and L leads to lysosomal dysfunction, NPC-like cholesterol sequestration and accumulation of the key Alzheimer's proteins","volume":"11","author":"Cermak","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0395","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0400","doi-asserted-by":"crossref","first-page":"39834","DOI":"10.1074\/jbc.M112.371641","article-title":"Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0405","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease","volume":"60","author":"Sun","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0410","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbrc.2009.05.131","article-title":"Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein","volume":"386","author":"Hook","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0415","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1074\/jbc.RA119.008930","article-title":"C-terminal alpha-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease","volume":"294","author":"McGlinchey","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0420","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.wnr.0000134931.81690.34","article-title":"Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells","volume":"15","author":"Luhr","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0425","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1021\/acs.biochem.7b00360","article-title":"Taking a bite out of amyloid: mechanistic insights into alpha-synuclein degradation by cathepsin L","volume":"56","author":"McGlinchey","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166205","article-title":"Analysis of cathepsin B and cathepsin L treatment to clear toxic lysosomal protein aggregates in neuronal ceroid lipofuscinosis","volume":"1867","author":"Di Spiezio","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0435","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0440","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2013the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0445","first-page":"1795","article-title":"The neuronal ceroid-lipofuscinoses: a historical introduction","volume":"2013","author":"Haltia","year":"1832","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0450","first-page":"83","article-title":"Neuronal ceroid-lipofuscinoses","volume":"3","author":"Rakheja","year":"2018","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0455","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00415-016-8111-6","article-title":"Early infantile neuronal ceroid lipofuscinosis (CLN10 disease) associated with a novel mutation in CTSD","volume":"263","author":"Doccini","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0460","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-008-0426-7","article-title":"Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10)","volume":"117","author":"Fritchie","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0465","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.0000000000000981","article-title":"Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology","volume":"83","author":"Hersheson","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0470","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/504159","article-title":"Cathepsin D deficiency is associated with a human neurodegenerative disorder","volume":"78","author":"Steinfeld","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0475","article-title":"Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified alpha-synuclein degradation properties","volume":"9","author":"Bunk","year":"2021","journal-title":"Front CellDev. Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0480","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/emboj\/19.12.2786","article-title":"A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration","volume":"19","author":"Tyynela","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0485","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2005.11.005","article-title":"A mutation in the cathepsin D gene (CTSD) in american bulldogs with neuronal ceroid lipofuscinosis","volume":"87","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0490","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/j.1460-2075.1995.tb00029.x","article-title":"Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells","volume":"14","author":"Saftig","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/nen.0b013e31815f3899","article-title":"Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis","volume":"67","author":"Partanen","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0500","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2009.06440.x","article-title":"Murine cathepsin D deficiency is associated with dysmyelination\/myelin disruption and accumulation of cholesteryl esters in the brain","volume":"112","author":"Mutka","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0505","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0047-6374(98)00073-6","article-title":"Ceroid\/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis","volume":"104","author":"Terman","year":"1998","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0510","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0531-5565(99)00070-4","article-title":"Ceroid\/lipofuscin-loaded human fibroblasts show decreased survival time and diminished autophagocytosis during amino acid starvation","volume":"34","author":"Terman","year":"1999","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0515","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0520","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0525","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","article-title":"Alpha-synuclein in Parkinson's disease: causal or bystander?","volume":"126","author":"Riederer","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0530","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"2180","key":"10.1016\/j.bbamcr.2022.119243_bb0535","first-page":"e2181","article-title":"Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0540","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes parkinson and lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0545","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0550","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0555","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0560","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(98)01146-6","article-title":"Synthetic filaments assembled from C-terminally truncated alpha-synuclein","volume":"436","author":"Crowther","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0565","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/s41467-020-16564-3","article-title":"Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity","volume":"11","author":"Stephens","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0570","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0575","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1073\/pnas.0401081101","article-title":"Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and lewy bodies imply a role in Parkinson's disease","volume":"101","author":"Liani","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0580","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","article-title":"Alpha-synuclein and protein degradation systems: a reciprocal relationship","volume":"47","author":"Xilouri","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0585","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0590","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0595","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0600","doi-asserted-by":"crossref","first-page":"27447","DOI":"10.1016\/S0021-9258(19)61529-2","article-title":"Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state","volume":"275","author":"Salvador","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.283","article-title":"Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of alpha-synuclein aggregates","volume":"6","author":"Bae","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0610","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2022.2045534","article-title":"Recombinant pro-CTSD (cathepsin D) enhances SNCA\/\u03b1-synuclein degradation in \u03b1-synucleinopathy models","author":"Prieto Huarcaya","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0615","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of alpha-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0620","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","article-title":"Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide","volume":"97","author":"Zunke","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0625","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0630","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0635","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1021\/acs.biomac.0c00629","article-title":"Toxic metamorphosis-how changes from lysosomal to cytosolic pH modify the alpha-synuclein aggregation pattern","volume":"21","author":"Eymsh","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0640","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0645","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0650","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0655","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy","volume":"286","author":"Choubey","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0660","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1091\/mbc.e14-02-0741","article-title":"Formation of alpha-synuclein lewy neurite-like aggregates in axons impedes the transport of distinct endosomes","volume":"25","author":"Volpicelli-Daley","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0670","doi-asserted-by":"crossref","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","article-title":"Alpha-synuclein oligomers impair neuronal microtubule-kinesin interplay","volume":"288","author":"Prots","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0675","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0680","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0685","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0690","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0695","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0700","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0705","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0715","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0720","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0725","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mds.27556","article-title":"Gut-brain axis and the spread of alpha-synuclein pathology: vagal highway or dead end?","volume":"34","author":"Breen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0730","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13777","article-title":"The gut in Parkinson's disease: bottom-up, top-down, or neither?","volume":"32","author":"Leclair-Visonneau","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0735","doi-asserted-by":"crossref","first-page":"573696","DOI":"10.3389\/fcell.2020.573696","article-title":"Alpha synuclein connects the gut-brain axis in Parkinson's disease patients - a view on clinical aspects, cellular pathology and analytical methodology","volume":"8","author":"Schaeffer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0740","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0745","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0750","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.bbamcr.2022.119243_bb0755","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson's disease caused by SNCA duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0760","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson's disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0765","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.11.015","article-title":"Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics","volume":"73","author":"Senkevich","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0770","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0775","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0780","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0785","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0790","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/hmg\/ddu299","article-title":"Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins","volume":"23","author":"Motta","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0795","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0800","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0805","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson's disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0810","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple system atrophy","volume":"3","author":"Wenning","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0815","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0820","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0825","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","article-title":"p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy","volume":"171","author":"Song","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0830","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0835","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jnnp.2008.158949","article-title":"Definite multiple system atrophy in a german family","volume":"80","author":"Wullner","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0840","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2005.09.003","article-title":"Heredity in multiple system atrophy","volume":"240","author":"Soma","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0845","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.64.4.545","article-title":"Multiplex families with multiple system atrophy","volume":"64","author":"Hara","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007114","article-title":"Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy","volume":"4","author":"Al-Chalabi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0855","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","article-title":"SNCA variants are associated with increased risk for multiple system atrophy","volume":"65","author":"Scholz","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0860","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0865","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-012-9733-5","article-title":"Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes","volume":"47","author":"Schwarz","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0870","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/WNR.0b013e3283503e4f","article-title":"Activation and alteration of lysosomes in multiple system atrophy","volume":"23","author":"Makioka","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0875","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/nan.12512","article-title":"Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of alpha-synuclein in multiple system atrophy","volume":"45","author":"Kiely","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0880","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Neuroscience: Alzheimer's disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0885","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0890","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","article-title":"Abeta secretion and plaque formation depend on autophagy","volume":"5","author":"Nilsson","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0900","first-page":"141","article-title":"Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors","volume":"378","author":"Turk","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0905","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.55.6.763","article-title":"A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease","volume":"55","author":"Crawford","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0910","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archneur.57.11.1579","article-title":"Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease","volume":"57","author":"Finckh","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0915","first-page":"111","article-title":"The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia","volume":"46","author":"Lin","year":"2003","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0920","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.3700","article-title":"Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease","volume":"20","author":"Zhang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0925","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0930","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0935","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0940","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005072-199902000-00003","article-title":"Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain","volume":"58","author":"Maat-Schieman","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0945","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199902000-00006","article-title":"Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease","volume":"58","author":"Sapp","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0950","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0955","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","article-title":"Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy","volume":"20","author":"Kegel","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0960","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1326-5-58","article-title":"Huntingtin cleavage product a forms in neurons and is reduced by gamma-secretase inhibitors","volume":"5","author":"Kegel","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0965","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/CMR.12.3.429","article-title":"Cellular biology of prion diseases","volume":"12","author":"Harris","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0970","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/neup.12016","article-title":"Human prion diseases: molecular, cellular and population biology","volume":"33","author":"Head","year":"2013","journal-title":"Neuropathology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0975","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.278.5336.245","article-title":"Prion diseases and the BSE crisis","volume":"278","author":"Prusiner","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb0980","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.90.23.10962","article-title":"Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins","volume":"90","author":"Pan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0985","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0990","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/jvi.65.12.6597-6603.1991","article-title":"N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state","volume":"65","author":"Caughey","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb0995","doi-asserted-by":"crossref","first-page":"12259","DOI":"10.1128\/JVI.76.23.12259-12264.2002","article-title":"Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro","volume":"76","author":"Luhr","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1000","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1128\/JVI.78.20.11051-11060.2004","article-title":"Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology","volume":"78","author":"Xiang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000246343","article-title":"Genetic association of a cathepsin D polymorphism and sporadic creutzfeldt-Jakob disease","volume":"28","author":"Jeong","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/WAD.0b013e3181ad378c","article-title":"Cathepsin D (C224T) polymorphism in sporadic and genetic Creutzfeldt-Jakob disease","volume":"24","author":"Kovacs","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2350-9-31","article-title":"Cathepsin D SNP associated with increased risk of variant creutzfeldt-Jakob disease","volume":"9","author":"Bishop","year":"2008","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00684430","article-title":"Creutzfeldt-Jakob disease: a histochemical study with microdensitometric assay of some enzymes","volume":"26","author":"Timperley","year":"1973","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/271778a0","article-title":"Transmission of creutzfeldt-Jakob disease with scrapie-like syndromes to mice","volume":"271","author":"Manuelidis","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in parkinson's disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/mds.25495","article-title":"Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease","volume":"28","author":"van Dijk","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-019-0533-9","article-title":"Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease","volume":"11","author":"Sj\u00f6din","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1045","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","article-title":"Characterization of brain lysosomal activities in GBA-related and sporadic Parkinson's disease and dementia with Lewy bodies","volume":"56","author":"Moors","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cts.12920","article-title":"Identification of BAG2 and cathepsin D as plasma biomarkers for Parkinson's disease","volume":"14","author":"Kang","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1060","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/mds.21399","article-title":"Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease","volume":"22","author":"Balducci","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bpa.12631","article-title":"Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration","volume":"29","author":"Chai","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081806","article-title":"A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer's disease and MCI patients: implications for regenerative medicine approaches","volume":"18","author":"Morena","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1080","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-2010-101023","article-title":"Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls","volume":"22","author":"Sundel\u00f6f","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1995.64010443.x","article-title":"Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in alzheimer disease","volume":"64","author":"Schwagerl","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1090","article-title":"Identification of cathepsin D as a plasma biomarker for Alzheimer's disease","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1105","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1110","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4161\/auto.2156","article-title":"Neurodegeneration induces upregulation of beclin 1","volume":"2","author":"Erlich","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1120","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2016.04.041","article-title":"Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro","volume":"108","author":"Walter","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1130","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1135","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1145","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","article-title":"Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in Parkinson's patient midbrain neurons","volume":"36","author":"Mazzulli","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1150","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces alpha-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and Parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.24790","article-title":"Ambroxol effects in glucocerebrosidase and alpha-synuclein transgenic mice","volume":"80","author":"Migdalska-Richards","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1252-3","article-title":"Ambroxol as a novel disease-modifying treatment for Parkinson\u2019s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial","volume":"19","author":"Silveira","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1170","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108489118","article-title":"Pathological \u03b1-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of \u03b1-syn in vivo","volume":"118","author":"Fredriksen","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cpdd.865","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of oral venglustat in healthy volunteers","volume":"10","author":"Peterschmitt","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1185","first-page":"757","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2020","volume":"10","author":"McFarthing","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/ph14080717","article-title":"Current therapies in clinical trials of Parkinson\u2019s disease: a 2021 update","volume":"14","author":"Prasad","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1195","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34490-9","article-title":"The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease","volume":"8","author":"Price","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1205","series-title":"Results From a Phase 1b Study of UCB0599, an Orally Available, Brain-penetrant Inhibitor of Alphasynuclein (ASYN) Misfolding in People Living with Parkinson\u2019s Disease (PD)(2025)","author":"Genius","year":"2021"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1210","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"\u03b1-Synuclein\u2013induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuron.2019.09.001","article-title":"Stress-induced cellular clearance is mediated by the SNARE protein ykt6 and disrupted by \u03b1-synuclein","volume":"104","author":"Cuddy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1220","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrd3556","article-title":"Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development","volume":"10","author":"Ehrnhoefer","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1225","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1230","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1235","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s42003-020-0757-z","article-title":"Augmentation of Bri2 molecular chaperone activity against amyloid-beta reduces neurotoxicity in mouse hippocampus in vitro","volume":"3","author":"Chen","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1250","doi-asserted-by":"crossref","first-page":"21765","DOI":"10.1038\/s41598-020-78732-1","article-title":"Functionalization of amyloid fibrils via the Bri2 BRICHOS domain","volume":"10","author":"Biverstal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1255","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1021\/bi400908x","article-title":"The BRICHOS domain, amyloid fibril formation, and their relationship","volume":"52","author":"Knight","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1260","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-a beta antibody alters CNS and plasma a beta clearance and decreases brain a beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fimmu.2019.01139","article-title":"The role of antibodies and their receptors in protection against ordered protein assembly in neurodegeneration","volume":"10","author":"Katsinelos","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-beta monoclonal antibodies for Alzheimer's disease: pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbamcr.2022.119243_bb1285","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.bbamcr.2022.119243_bb1290","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488922000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488922000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:08:57Z","timestamp":1777500537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488922000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":257,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0167488922000349"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119243","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119243"}}